Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting

At the 2020 annual meeting of Group for Research and Assessment Psoriasis Psoriatic Arthritis (GRAPPA), International Dermatology Outcome Measures (IDEOM) Initiative (PsO) Working presented an update on its work to agree meaningful, valid, feasible outcome measures PsO randomized controlled trials longitudinal observational studies. The Treatment Satisfaction development a treatment satisfaction instrument be utilized in clinical trials. Musculoskeletal Symptoms overview their conducted date define how best measure musculoskeletal symptoms studies, discussed next steps during open-panel discussion, which included psoriatic arthritis experts.